Share
This week on the Olive Health Information System
The newsletter of the University of Navarra and the IOC dedicated to health
Article 1
Recent research in the field of olive-related products continues to progress along two complementary but distinct lines: the analytical characterization of bioactive compounds in olive oil, and the evaluation of biological effects derived from Olea europaea leaf extracts. Together, these approaches help bridge the gap between chemical composition and potential physiological effects. The studies selected this week illustrate both ends of this spectrum, highlighting the importance of robust analytical methodologies as well as early-stage biological evidence from experimental models of oxidative stress.
The first set of studies focuses on the analytical characterization of bioactive compounds in olive-derived matrices. One study uses Fourier Transform Near-Infrared Spectroscopy to profile phenolic compounds in virgin olive oil, while the other combines High-speed shear extraction and liquid chromatography to quantify triterpenoid compounds in olive pomace. Both papers address the challenge of accurately identifying and quantifying bioactive constituents within the complex olive oil matrix. They emphasize the development and application of advanced analytical methodologies designed to improve sensitivity, selectivity, and reproducibility in the measurement of minor compounds. These contributions are particularly relevant for standardizing analytical approaches across studies, improving comparability of results, and strengthening the link between olive oil composition, dietary exposure, and potential health outcomes.
The second study investigates the hepatoprotective effects of Olea europaea leaf extract against oxidative stress in experimental hepatocyte and zebrafish embryo models. The results suggest that compounds present in olive leaf extracts may reduce oxidative damage and modulate cellular responses to reactive oxygen species, indicating potential cytoprotective properties. However, these findings are based on early-stage experimental models and should be interpreted as mechanistic and exploratory rather than directly translatable to humans. Nonetheless, they provide valuable insight into the antioxidant potential of olive leaf constituents and their possible role in oxidative stress-related pathways.
Taken together, these studies remind us that the strength of health-related research on olive-derived products begins with precision: knowing what compounds are present, in what amounts, and how they may act in biological systems. Improved analytical tools and early experimental models both contribute to building that evidence, although further clinical research is still needed.
Article 2
Mild cognitive impairment, dementia, and age-related muscle loss, or sarcopenia, are among the most important public health challenges associated with ageing. Given the limited effectiveness of current pharmacological treatments, researchers are increasingly exploring nutritional interventions that may help preserve cognitive function and support muscle integrity. Extra virgin olive oil has emerged as a promising dietary component due to its rich profile of bioactive phytochemicals and healthy fats. Among its most notable compounds are oleocanthal, a potent anti-inflammatory agent, and hydroxytyrosol, a powerful natural antioxidant. These compounds are thought to act on key mechanisms involved in neurodegeneration, including neuroinflammation, oxidative stress, and beta-amyloid aggregation.
A recent systematic review and meta-analysis of randomized controlled trials examined the effects of olive oil and its constituents on cognitive outcomes in older adults. The review focused on whether extra virgin olive oil consumption could improve cognitive function in adults aged 60 years and older with mild cognitive impairment, dementia, or age-related cognitive decline. Across five eligible trials, including 747 participants and follow-up periods ranging from 6 months to 6.5 years, extra virgin olive oil supplementation was associated with modest but statistically significant improvements in cognitive performance. In particular, participants in the extra virgin olive oil groups achieved better scores on the Mini-Mental State Examination and the Alzheimer’s Disease Assessment Scale–Cognitive Subscale.
Olive-derived compounds may also have potential in the context of sarcopenia, a condition closely linked to frailty, disability, metabolic dysfunction, and increased mortality. Oxidative stress and chronic low-grade inflammation are considered important contributors to age-related muscle decline. In this context, a recent pilot study evaluated whether Oliphenolia®, a polyphenol-rich extract derived from olive mill wastewater, could influence muscle-related and antioxidant parameters in adults at metabolic risk. After 30 days of supplementation followed by a 30-day washout period, the study reported modest but consistent changes suggesting preservation of muscle-related indicators, improved systemic antioxidant status, and reduced fat mass. However, because this was a small, single-arm pilot study and the effects were not uniformly statistically significant, the findings should be interpreted as preliminary and hypothesis-generating.
Overall, recent evidence points to a promising role for extra virgin olive oil and olive-derived bioactive compounds in supporting healthy ageing, particularly in relation to cognitive function and muscle health. However, larger, well-designed randomized controlled trials are needed to confirm these findings, clarify the underlying mechanisms, and determine whether these benefits can be sustained over the long term.
Other articles mentioned this week in the OHIS newsletter:
Olives fruit and olive oil
Women’s health
Adherence to dietary patterns and their association with perinatal depression: a Scoping review.
Chronic diseases
Mediterranean Diet
Metabolic disorders
Cognitive health
Others
